SG10202005439XA - Method for evaluating quality of human mesenchymal stem cell, and monoclonal antibody for use in said method - Google Patents

Method for evaluating quality of human mesenchymal stem cell, and monoclonal antibody for use in said method

Info

Publication number
SG10202005439XA
SG10202005439XA SG10202005439XA SG10202005439XA SG10202005439XA SG 10202005439X A SG10202005439X A SG 10202005439XA SG 10202005439X A SG10202005439X A SG 10202005439XA SG 10202005439X A SG10202005439X A SG 10202005439XA SG 10202005439X A SG10202005439X A SG 10202005439XA
Authority
SG
Singapore
Prior art keywords
monoclonal antibody
stem cell
mesenchymal stem
human mesenchymal
evaluating quality
Prior art date
Application number
SG10202005439XA
Other languages
English (en)
Inventor
Yumi Iyoku
Hideyuki Okano
Yo Mabuchi
Original Assignee
Purec Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Purec Co Ltd filed Critical Purec Co Ltd
Publication of SG10202005439XA publication Critical patent/SG10202005439XA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0652Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662Stem cells
    • C12N5/0663Bone marrow mesenchymal stem cells (BM-MSC)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/02Preparation of hybrid cells by fusion of two or more cells, e.g. protoplast fusion
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y207/00Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/10Protein-tyrosine kinases (2.7.10)
    • C12Y207/10001Receptor protein-tyrosine kinase (2.7.10.1)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966Animal cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705Assays involving receptors, cell surface antigens or cell surface determinants
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/91Transferases (2.)
    • G01N2333/912Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
SG10202005439XA 2014-08-01 2015-07-31 Method for evaluating quality of human mesenchymal stem cell, and monoclonal antibody for use in said method SG10202005439XA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2014157367 2014-08-01

Publications (1)

Publication Number Publication Date
SG10202005439XA true SG10202005439XA (en) 2020-07-29

Family

ID=55217690

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10202005439XA SG10202005439XA (en) 2014-08-01 2015-07-31 Method for evaluating quality of human mesenchymal stem cell, and monoclonal antibody for use in said method
SG11201610795VA SG11201610795VA (en) 2014-08-01 2015-07-31 Method for evaluating quality of human mesenchymal stem cell, and monoclonal antibody for use in said method

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG11201610795VA SG11201610795VA (en) 2014-08-01 2015-07-31 Method for evaluating quality of human mesenchymal stem cell, and monoclonal antibody for use in said method

Country Status (8)

Country Link
US (2) US20170204374A1 (https=)
EP (1) EP3176253B1 (https=)
JP (3) JP6850944B2 (https=)
AU (1) AU2015297347B2 (https=)
CA (1) CA2954245C (https=)
ES (1) ES2927112T3 (https=)
SG (2) SG10202005439XA (https=)
WO (1) WO2016017795A1 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11293065B2 (en) 2016-03-14 2022-04-05 Aelan Cell Technologies, Inc. Compositions and methods for the quality control of stem cell preparations
WO2020205732A1 (en) * 2019-03-29 2020-10-08 The Johns Hopkins University Grid of responses indicating drug sensitivity
CN112094804B (zh) * 2019-06-18 2024-05-14 中国医学科学院基础医学研究所 一种异质性干细胞群、其制备方法及用途
US12460182B2 (en) 2019-08-19 2025-11-04 Cellaxia Inc. Cell-containing pharmaceutical composition
WO2021144995A1 (ja) * 2020-01-16 2021-07-22 PuREC株式会社 高純度間葉系幹細胞
US20240018588A1 (en) * 2020-12-07 2024-01-18 Samsung Life Public Welfare Foundation Method for selecting mesenchymal stem cells having improved self-maintenance ability, and mesenchymal stem cells selected thereby
TW202246491A (zh) * 2021-01-29 2022-12-01 國立大學法人北海道大學 椎間盤再生用組成物
WO2022177032A1 (ja) 2021-02-19 2022-08-25 PuREC株式会社 骨疾患治療用医薬組成物
JP7368679B2 (ja) * 2021-09-01 2023-10-25 イミュニティリサーチ株式会社 細胞集団同定システム、方法、およびプログラム
CN116486909A (zh) * 2022-01-14 2023-07-25 天士力干细胞产业平台有限公司 一种干细胞质量评价系统
WO2023189485A1 (ja) 2022-03-31 2023-10-05 株式会社サイト-ファクト 間葉系幹細胞の品質評価方法
AU2024354962A1 (en) 2023-10-02 2026-03-12 National University Corporation Tokai National Higher Education And Research System Method for managing quality of stem cells by image analysis using ai
CN120322547A (zh) * 2023-10-26 2025-07-15 京东方科技集团股份有限公司 细胞培养方法、筛选方法以及间充质干细胞
WO2025187668A1 (ja) * 2024-03-06 2025-09-12 国立研究開発法人産業技術総合研究所 骨分化能判定方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004094641A2 (en) 2003-04-16 2004-11-04 Wyeth A novel method of modulating bone-realted activity
CA2628221A1 (en) * 2005-10-31 2007-05-10 Oncomed Pharmaceuticals, Inc. Anti-frizzled receptor antibodies for treating cancer
PE20071309A1 (es) * 2006-02-17 2008-02-13 Wyeth Corp Anticuerpos para la modulacion de formacion de huesos
WO2009011546A2 (en) 2007-07-16 2009-01-22 Catholic University Industry Academic Cooperation Foundation Method for promoting the self-renewal of adult stem cells using mesenchymal stromal cells
JP2009060840A (ja) * 2007-09-06 2009-03-26 Keio Gijuku ヒト間葉系幹細胞濃縮方法
US20130209415A1 (en) 2010-06-03 2013-08-15 The Board Of Trustees Of The Leland Stanford Junior University Purified compositions of cardiovascular progenitor cells
US20120087868A1 (en) 2010-10-08 2012-04-12 Gabriele Todd Nanoparticle-loaded cells
JP2013066414A (ja) * 2011-09-22 2013-04-18 National Institute Of Advanced Industrial Science & Technology 胃前駆細胞の表面マーカー
JP6463029B2 (ja) * 2013-08-02 2019-01-30 有未 伊谷 ヒト間葉系幹細胞を特異的に認識するモノクローナル抗体並びにこれを用いたヒト間葉系幹細胞の分離及び/または品質評価を行う方法
JP5924750B2 (ja) 2014-05-01 2016-05-25 iHeart Japan株式会社 Cd82陽性心筋前駆細胞

Also Published As

Publication number Publication date
AU2015297347A1 (en) 2017-01-19
US20210230553A1 (en) 2021-07-29
CA2954245C (en) 2023-07-25
CA2954245A1 (en) 2016-02-04
JP6850944B2 (ja) 2021-04-14
JPWO2016017795A1 (ja) 2017-06-22
EP3176253A4 (en) 2018-03-21
EP3176253B1 (en) 2022-08-24
US11441123B2 (en) 2022-09-13
AU2015297347B2 (en) 2021-05-27
JP2020072662A (ja) 2020-05-14
WO2016017795A1 (ja) 2016-02-04
US20170204374A1 (en) 2017-07-20
JP6932390B2 (ja) 2021-09-08
ES2927112T3 (es) 2022-11-02
EP3176253A1 (en) 2017-06-07
JP2021100414A (ja) 2021-07-08
SG11201610795VA (en) 2017-02-27

Similar Documents

Publication Publication Date Title
SG11201610795VA (en) Method for evaluating quality of human mesenchymal stem cell, and monoclonal antibody for use in said method
IL282962A (en) Anti-PD-1 antibodies and methods of using them
IL270366A (en) Anti-CD3 binding sites and antibodies containing them, and methods of making and using them
SG10201912489QA (en) Chimeric antigen and t cell receptors and methods of use
IL252280A0 (en) Anti pd-1 antibodies and methods of using them
IL256086A (en) Anti-her2 antibodies and methods of use
DK3105252T3 (da) Bispecifikke antistoffer til anvendelse ved stamcelletransplantation
SG11201803330WA (en) Methods for culturing cells and kits and apparatus for same
SG11201705252UA (en) Anti-pd-1 monoclonal antibodies and obtaining method thereof
SG10202000834WA (en) Antibody constructs for cd70 and cd3
IL251128A0 (en) Bispecific antibodies and methods of use in ophthalmology
SG10202106515SA (en) Methods and kits for generating mimetic innate immune cells from pluripotent stem cells
EP3160505A4 (en) Anti-pd-l1 antibodies and their use as therapeutics and diagnostics
ZA201700488B (en) Method for positioning, in cytoplasm, antibody having complete immunoglobulin form by penetrating antibody through cell membrane, and use for same
IL252008A0 (en) Methods for producing bispecific domains, variants of antibodies and their use
PT3116911T (pt) Anticorpos anti-mcam e métodos de utilização associados
ZA201703710B (en) Dna antibody constructs and method of using same
IL247754A0 (en) Antibodies against mcam and related methods of use
ZA202003858B (en) Monoclonal antibodies and methods for using same
GB201617572D0 (en) Use, method, kit, composition and antibodies
IL256997B (en) Anti-cd154 antibodies and methods of using them
SG11201800872QA (en) Chimeric antigen receptor, and t cells in which chimeric antigen receptor is expressed
IL260858B (en) Mesenchymal stem cells as vaccine adjuvants and methods for using the same
SG11201610878QA (en) Mutant hemagglutinin complex protein, and method for culturing pluripotent stem cells using same
IL273987A (en) Methods for diagnosing mesenchymal stem cells